Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438)

Serge Léger1, W Cameron Black, Denis Deschenes

  • 1Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire-Dorval, Québec, Canada H9R 4P8.